Polo‐like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades
The Prostate2004Vol. 60(3), pp. 240–245
Citations Over TimeTop 10% of 2004 papers
Wilko Weichert, Mathias Schmidt, Volker Gekeler, Carsten Denkert, Carsten Stephan, Klaus Jung, Stefan A. Loening, Manfred Dietel, Glen Kristiansen
Abstract
These results demonstrate a high rate of PLK1-positivity in prostate cancer which suggests involvement of PLK1 in tumorigenesis and progression in this tumor entity. Therefore, targeted strategies focussing on PLK1 inhibition might represent a promising new chemotherapeutic approach in prostate cancer.
Related Papers
- → Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic Hyperplasia(1979)309 cited
- → Morphometric Evaluation of Benign Prostatic Hyperplasia(1990)29 cited
- Effect of Qianliean on Basic Fibroblast Growth Factorlevelsin in Rats Model of Benign Prostatic Hyperplasia(2010)
- Experimental Study on Prostate restored Capsule Suppressing Benign Prostate Hyperplasia(2000)
- Effect of Activating Blood Circulation and Dipelling Stasis Therapy on Expression of bFGF in Prostate Tissue of Rats with Prostatic Hyperplasia(2008)